The synthetic DNA manufacturer reported 13 straight quarters of growth, driven by higher customer shipments and improved gross margins. Twist Bioscience posted Q2 2026 revenue of $110.7 million, a 19% increase from $92.8 million in the same period last year. The company at
Acadia Healthcare shares rise as two firms lift price targets following stronger-than-expected Q1 earnings and raised guidance. Acadia Healthcare (NASDAQ:ACHC) surged after RBC Capital raised its price target to $31 from $28 and maintained an Outperform rating. The upgrade
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best performing healthcare stocks so far in 2026. Revolution Medicines, Inc. (NASDAQ:RVMD) announced on May 1 that the U.S Food and Drug Administration (FDA) issued a “safe to proceed” letter to the company, all
Oruka Therapeutics, Inc. (NASDAQ:ORKA) is one of the best performing healthcare stocks so far in 2026. Leerink Partners lifted the price target on Oruka Therapeutics, Inc. (NASDAQ:ORKA) to $120 from $109 on April 30, reaffirming an Outperform rating on the shares In
Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc. (NASDAQ:TNGX) to $40 from $24 on April 27, maintaining a Buy rating on the shares The firm cited elevate
Erasca, Inc. (NASDAQ:ERAS) is one of the best performing healthcare stocks so far in 2026. The Fly reported on May 4 that JPMorgan is maintaining an Overweight rating on Erasca, Inc. (NASDAQ:ERAS) and recommends buying the stock at current levels The firm believes t
Veradermics, Incorporated (NYSE:MANE) is one of the best performing healthcare stocks so far in 2026. On April 27, Citi lifted the price target on Veradermics, Incorporated (NYSE:MANE) to $120 from $85, reaffirming a Buy rating on the shares The rating update came a
Revenue declined to $795 million in the quarter Hyster-Yale's first-quarter results reflected a challenging lift truck market, with revenue declining to $795 million. The decrease was driven primarily by the normalization of excess backlog and a mix shift toward li
Cenovus Energy aims for 1 million BOE/day exit rate in 2026 after shareholders approve all board and auditor votes. Cenovus Energy (NYSE:CVE) shareholders approved all voting items at the company’s annual meeting, including the election of directors and the appointment of
The software firm raised full-year guidance after strong customer growth and AI monetization drove first-quarter results above expectations. HubSpot reported Q1 2026 revenue growth of 23% year over year, reaching $154 million in free cash flow and an 18% non-GAAP operating
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.